Physician profile
Kara Sue Hoffman
NPI 1942794714
$1,769.15
in general payments reported to CMS, 2019-2025
26 companies · $687 in 2025
The $687 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $284 · 2022: $103 · 2023: $105 · 2024: $589 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $226.46 | 2021-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $203.66 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $176.25 | 2023-2025 | Gemtesa |
| Axonics, INC. | $160.91 | 2024 | Axonics |
| Urogen Pharma, INC. | $138.63 | 2025 | |
| Myriad Genetic Laboratories, INC. | $126.62 | 2024-2025 | Prolaris |
| Teleflex LLC | $80.86 | 2024-2025 | Urolift |
| Boston Scientific Corporation | $78.87 | 2022-2025 | Greenlight Xps, Ams 700, Axonics |
| 180 Medical, INC. | $69.76 | 2021-2024 | Magic3 Intermittent Catheter |
| Profound Medical Corp. | $54.82 | 2021 | |
| Convatec INC. | $53.28 | 2024 | |
| Procept Biorobotics Corporation | $46.61 | 2025 | |
| Pfizer INC. | $44.99 | 2024 | |
| Endo USA, INC. | $42.22 | 2025 | Xiaflex |
| Olympus America INC. | $37.32 | 2025 | Itind System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $30.68 | 2021 | |
| Immunitybio, INC. | $29.12 | 2025 | |
| Merck Sharp & Dohme LLC | $25.42 | 2025 | Bridion |
| Myovant Sciences INC. | $25.21 | 2021 | |
| Ambu INC. | $19.98 | 2024 | |
| Progenics Pharmaceuticals, INC. | $19.73 | 2024 | |
| Tolmar, INC. | $19.04 | 2025 | Eligard |
| Blue Earth Diagnostics | $18.33 | 2021 | |
| Coloplast Corp | $16.49 | 2025 | |
| Srs Medical Systems, INC. | $12.62 | 2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Rochester Medical Corporation | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.